Today: 1 July 2026
Browse Category

NASDAQ:INMD 19 May 2026

InMed Soars 100% on $290M Migraine Deal

InMed Soars 100% on $290M Migraine Deal

InMed Pharmaceuticals shares jumped over 100% in busy Nasdaq trading Tuesday. The Vancouver drug developer said it will merge with private Mentari Therapeutics in an all-stock deal, aiming to bring the public company into migraine prevention therapies. The stock jumped 108.6% to $1.42 in the latest trade after reaching an intraday high of $2.04. Volume was heavy—about 69.6 million shares traded, much higher than usual for the microcap biotech. The company’s market value was close to $5.7 million.
19 May 2026
·

Stock Market Today

  • Ralph Lauren (RL) beats peers on EPS and cash flow growth estimates
    July 1, 2026, 2:40 PM EDT. Ralph Lauren (RL) is posting stronger growth numbers than much of its industry. The company's EPS is estimated to rise 11.4% this year, compared to the industry's drop of 4.1%. Cash flow growth is running at 10.2%, with the sector at -5.4%. Earnings estimates for the current year have ticked up 0.5% over the past month. RL holds a high Zacks Growth Style Score and a top Zacks Rank, which has caught attention from growth investors navigating market swings.
Go toTop